Post-approval studies (Phase 4)Study completedNCT01926015
What this trial is testing
Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)
Who this might be right for
Rotavirus Disease
Merck Sharp & Dohme LLC 192